Inovalon
Corporate brand
UnclaimedUnited States healthcare data analytics and technology company
Last updated August 24, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Inovalon is a United States healthcare technology company that develops cloud-based data, analytics, connectivity, and workflow tools for organizations across the healthcare system. Its customers and users have included health plans, hospitals and other providers, pharmacies, pharmaceutical companies, and medical-supply businesses. The company’s central proposition is that healthcare organizations can use connected clinical, administrative, pharmacy, and claims information to improve quality measurement, identify care gaps, support regulatory and reimbursement requirements, and make operational decisions. The business began in Maryland in 1998 under the name MedAssurant, founded by physician and entrepreneur Keith Dunleavy. Its early work focused on applying data and analytical methods to healthcare quality and performance problems. In June 2012, the company adopted the Inovalon name, reflecting a broader technology and information-services strategy. During the following years it developed relationships with healthcare researchers, Walgreens, electronic-health-record vendors, pharmaceutical companies, and large healthcare operators. These activities helped extend its role beyond retrospective reporting into point-of-care assessment, outcomes analysis, specialty-pharmacy management, and value-based or outcomes-based contracting. Inovalon became a public company during a period of expansion in healthcare analytics. It filed a registration statement for a proposed initial public offering with the U.S. Securities and Exchange Commission in December 2014 and began trading on Nasdaq under the symbol INOV on April 12, 2015. Its acquisition program included Avalere Health in 2015, adding policy, market, and strategic advisory capabilities serving pharmaceutical and managed-care organizations; Creehan Holding Company in 2016, adding specialty-pharmacy and specialty-medication management software; and ABILITY Network in 2018, a major expansion into cloud software and connectivity for healthcare providers and related organizations. The company also pursued a platform-oriented model. The Inovalon ONE Platform was positioned as a cloud environment for integrating healthcare data, analytics, quality improvement, and workflow capabilities. Related offerings included ePASS for patient assessment and engagement workflows and ScriptMed Cloud for specialty-pharmacy and medical-supply use cases. Engagements with organizations such as UnitedHealthcare, AllianceRx Walgreens Prime, Cardinal Health, and Walmart Specialty Pharmacy illustrated the company’s emphasis on embedding its tools into large healthcare enterprises rather than selling only stand-alone analytical reports. Inovalon’s research and commercial programs have addressed Medicare Advantage readmissions, the experiences of dual-eligible members, socioeconomic factors affecting measured quality, specialty-pharmacy operations, and outcomes-based contracting. Its work has therefore occupied an intersection between health information technology, payer and provider analytics, population health, pharmacy technology, and healthcare services. The company was acquired by Nordic Capital and Insight Partners in 2021 and ceased trading publicly in November of that year. In January 2025, Adam Kansler was appointed chief executive officer, succeeding the company’s founder, Keith Dunleavy. Inovalon remains an active privately held healthcare technology business focused primarily on the U.S. market.
History
Inovalon was established in Maryland in 1998 as MedAssurant by Keith Dunleavy, MD. The company developed around the use of healthcare data and analytics to evaluate quality, performance, and patient outcomes. Its work addressed problems faced by payers and providers that needed to combine clinical, administrative, claims, and pharmacy information in order to measure care and identify opportunities for improvement. In June 2012, MedAssurant changed its name to Inovalon. The rebranding accompanied a broadening of the business from healthcare analytical services toward a more integrated technology and information platform. In the same year, Inovalon worked with healthcare researchers on a study comparing hospital readmission rates for Medicare Advantage members with fee-for-service populations. The study was later published in The American Journal of Managed Care. The company expanded its healthcare connectivity and point-of-care activities during 2013 and 2014. It worked with Walgreens and electronic health-record companies including Allscripts, Greenway, and NeoDeck to connect analytical tools with clinical workflows. Inovalon also studied how socioeconomic status and other factors affected quality outcomes for dual-eligible Medicare Advantage members. Findings from this work were presented to congressional representatives and subsequently released publicly. In 2014, Inovalon expanded its relationship with Walgreens to deploy the ePASS patient-assessment tool in Walgreens clinics. The company became publicly traded in 2015 after filing its IPO registration statement in December 2014 and beginning Nasdaq trading in April 2015. That year it acquired Avalere Health, an advisory business serving pharmaceutical companies, managed-care organizations, and providers. The transaction gave Inovalon a broader presence in healthcare policy, market intelligence, and strategic consulting. Inovalon continued extending its portfolio through partnerships and acquisitions. It acquired Creehan Holding Company in 2016, adding software for specialty pharmacies and specialty medications. In 2017, it worked with Boehringer Ingelheim in connection with the company’s diabetes alliance with Eli Lilly to support outcomes-based contracting and patient-care initiatives. Inovalon also announced relationships with UnitedHealthcare and Daiichi Sankyo that year. UnitedHealthcare planned to implement the Inovalon ONE Platform, while the Daiichi Sankyo relationship focused on outcomes-based approaches to opioid pain management. In 2018, Inovalon acquired ABILITY Network, a Minneapolis-based cloud healthcare software company. The deal strengthened Inovalon’s connectivity and software capabilities across healthcare providers and related organizations. The company subsequently announced multi-year engagements with AllianceRx Walgreens Prime, Cardinal Health, and Walmart Specialty Pharmacy. These arrangements applied Inovalon technology to specialty pharmacy, durable medical equipment, medical supplies, and pharmacy-care workflows. The company’s principal platform strategy centered on Inovalon ONE, a cloud environment intended to bring together data integration, analytics, quality measurement, and operational tools. Other offerings included ePASS for patient assessment and ScriptMed Cloud for specialty-pharmacy and medical-supply processes. Together, these products reflected Inovalon’s effort to serve multiple parts of the healthcare value chain rather than focus solely on payer analytics. Inovalon was acquired by Nordic Capital and Insight Partners in 2021 and was taken private, ending its public-market trading. In August 2023, founder Keith Dunleavy was inducted into the Dartmouth Entrepreneur Hall of Fame. Adam Kansler became chief executive officer on January 28, 2025. Before joining Inovalon, Kansler held senior leadership positions at S&P Global Market Intelligence and IHS Markit, as well as practicing law at Proskauer. The company’s current identity is that of a privately held U.S. healthcare technology provider focused on cloud software, healthcare data, quality improvement, connectivity, and pharmacy-related operations.
- 2025
Adam Kansler appointed CEO
[1]Kansler became chief executive on January 28, 2025.
- 2021
Taken private
[1]Nordic Capital and Insight Partners acquired Inovalon, ending its public listing in November.
- 2018
ABILITY Network acquired
[1]The acquisition strengthened the company’s cloud-based healthcare software and connectivity business.
- 2016
Creehan Holding Company acquired
[1]Inovalon added specialty-pharmacy and specialty-medication management software.
- 2015
Public-market debut
[1]Shares began trading on Nasdaq on April 12, 2015.
- 2015
Avalere Health acquired
[1]The acquisition added healthcare advisory and market-intelligence capabilities.
- 2014
IPO registration filed
[1]Inovalon filed a registration statement for a proposed public offering and applied to list on Nasdaq under INOV.
- 2012
Company renamed Inovalon
[1]MedAssurant adopted the Inovalon name as the business expanded its healthcare technology and analytics activities.
- 1998
MedAssurant is founded
[1]Keith Dunleavy founded the Maryland healthcare analytics company that would later become Inovalon.
Products and positioning
A healthcare data and cloud-technology platform that connects analytics, quality improvement, clinical workflows, and pharmacy operations for payers, providers, life-sciences organizations, and healthcare suppliers.
Healthcare data and analytics platform
Inovalon ONE Platform
Inovalon ONE is the company’s principal cloud platform. It is designed to bring together healthcare data, analytics, quality measurement, and workflow capabilities for organizations including health plans, providers, pharmacies, and life-sciences companies. Its role is to support care-gap identification, performance analysis, interoperability, and operational decision-making across connected healthcare processes.
Patient assessment and care workflow technology
ePASS
ePASS is a patient-assessment tool and technology workflow associated with Inovalon’s point-of-care programs. It was used in clinic settings, including Walgreens locations, to support the collection and use of patient information for assessment, quality improvement, and care-management activities.
Specialty-pharmacy and medical-supply software
ScriptMed Cloud
ScriptMed Cloud is a cloud-based platform for specialty-pharmacy and related healthcare supply workflows. Inovalon has used the product in engagements involving specialty pharmacy, durable medical equipment, and medical supplies, with capabilities intended to support configuration, operational management, and improved coordination.
Healthcare advisory and market intelligence · 2015
Avalere Health services
Avalere Health added advisory, policy, market, and strategic capabilities to Inovalon’s portfolio after its 2015 acquisition. The business served pharmaceutical companies, managed-care organizations, and provider organizations, complementing Inovalon’s software and analytics activities with research and consulting services.
Marketing campaigns
- 2017Diabetes outcomes-based contracting initiative
United States
Inovalon partnered with Boehringer Ingelheim in connection with its diabetes alliance with Eli Lilly to support outcomes-based contracting and patient-care improvement.
Outcome. The initiative applied Inovalon’s analytics and technology capabilities to a pharmaceutical value-based care context.
- 2017Opioid pain-management outcomes initiative
United States
Inovalon and Daiichi Sankyo announced work to help develop outcomes-based contracts addressing opioid pain management.
Outcome. The partnership broadened Inovalon’s outcomes-contracting activity into pain-management treatment and pharmaceutical programs.
- 2014Walgreens ePASS deployment
United States
Inovalon expanded its Walgreens relationship by implementing ePASS in Walgreens clinic locations.
Outcome. The deployment extended patient-assessment technology into retail clinic settings.
- 2013Walgreens and EHR point-of-care integration
United States
Inovalon worked with Walgreens and EHR vendors including Allscripts, Greenway, and NeoDeck to connect healthcare analytics with point-of-care workflows.
Outcome. The initiative supported the company’s expansion from retrospective analytics into embedded clinical and patient-assessment use cases.
Brand decisions
2021
Take-private acquisitionM&ABackground
After several years as a Nasdaq-listed company, Inovalon entered an ownership transition led by Nordic Capital and Insight Partners.
Action taken
The investors acquired Inovalon and completed its transition to private ownership in November 2021.
Aftermath
Inovalon ceased public trading and its INOV ticker was retired.
2018
Acquisition of ABILITY NetworkM&ABackground
Inovalon wanted to strengthen its cloud-based software and connectivity capabilities across the healthcare provider market.
Action taken
Inovalon announced the acquisition of ABILITY Network in March 2018, with the transaction closing on April 2.
Aftermath
ABILITY Network expanded Inovalon’s healthcare SaaS and connectivity footprint.
Acquisition consideration. $1.2 billion (2018 acquisition)
2015
Acquisition of Avalere HealthM&ABackground
Inovalon sought to expand its reach into healthcare advisory, policy, pharmaceutical, and managed-care markets.
Action taken
Inovalon acquired Avalere Health on September 1, 2015.
Aftermath
The transaction added strategic advisory and market-intelligence capabilities to the company’s technology and analytics portfolio.
Acquisition consideration. $140 million (2015 acquisition)
2012
Rebrand from MedAssurant to InovalonStrategyBackground
The company was expanding beyond its original healthcare analytics identity into a broader technology, data, and connectivity platform.
Action taken
Management changed the corporate name to Inovalon in June 2012.
Aftermath
The Inovalon brand became the basis for subsequent platform development, partnerships, acquisitions, and public-market expansion.
Recent events
Reported
Inovalon announces availability of Inovalon Converged Risk Analytics[3]
Inovalon announced the availability of Inovalon Converged Risk Analytics, a SaaS solution that gives health plans access to risk adjustment and quality measurement analytics through a single platform.
Reported
Consortium announces agreement to acquire Inovalon[4]
Inovalon announced that it had entered into a definitive agreement to be acquired by an equity consortium led by Nordic Capital and joined by Insight Partners, 22C Capital, Inovalon founder and CEO Keith Dunleavy, and certain Inovalon Class B stockholders, in an all-cash transaction with an enterprise value of approximately $7.3 billion.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/inovalon · Editorial policy · How profiles are compiled